Wolverine Asset Management’s AEON Biopharma AEON Stock Holding History

Wolverine Asset Management’s Portfolio AEON Stock Details AEON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-418	Closed	-$305K	–	1797
2023 Q1	$305K	Buy	418 +34	+9%	+$24.7K	﹤0.01%	957
2022 Q4	$278K	Sell	384 -410	-52%	-$294K	﹤0.01%	1077
2022 Q3	$563K	Buy	794 +37	+5%	+$26.2K	0.01%	979
2022 Q2	$534K	Sell	757 -31	-4%	-$21.9K	0.01%	973
2022 Q1	$555K	Buy	788 +775	+5,962%	+$544K	0.01%	939
2021 Q4	$8K	Sell	13 -2,439	-99%	-$1.72M	﹤0.01%	1876
2021 Q3	$1.72M	Hold	2,452	–	–	0.01%	542
2021 Q2	$1.7M	Buy	+2,452	New	+$1.71M	0.01%	475

Other funds holding AEON

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

ECP

Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return

TCM

Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

WRBC

W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Wolverine Asset Management's AEON Position: Q2 2023 in Review

Wolverine Asset Management sold out of AEON Biopharma (AEON) in Q2 2023, closing a stake of 418 shares — an estimated $305K sold.

Wolverine Asset Management first reported a position in AEON in Q2 2021 and held it in 8 quarters. The position peaked at $1.72M in Q3 2021. 17 funds tracked by Wall St. Rank hold AEON as of Q2 2023.

Wolverine Asset Management reported no remaining AEON Biopharma position as of Q2 2023 after selling out during the quarter.
Wolverine Asset Management sold 418 AEON Biopharma shares in Q2 2023, an estimated $305K.
Wolverine Asset Management first reported a position in AEON Biopharma in Q2 2021 and held it in 8 quarters.
Wolverine Asset Management's AEON Biopharma position peaked at $1.72M in Q3 2021.
17 funds tracked by Wall St. Rank held AEON Biopharma as of Q2 2023.

Based on Wolverine Asset Management's 13F filing for Q2 2023, filed 7 Aug 2023.